Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

62
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
62
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

92
 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
92
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

68
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
68
Local Anesthetics: Adverse Effects01:12

Local Anesthetics: Adverse Effects

519
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
519
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

51
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
51
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

533
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
533

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of genomic science in males with breast cancer.

Nursing·2026
Same author

Beyond Checking a Box: Embracing and Navigating Ethical Authorship.

Clinical journal of oncology nursing·2026
Same author

Errors in Germline Biomarker Testing: Significant Consequences and Missed Opportunities for Cancer Control in Patients and Their Families.

Cancer journal (Sudbury, Mass.)·2026
Same author

Quality and Safety Imperatives in the Identification and Management of Hereditary Cancer Syndromes.

Seminars in oncology nursing·2026
Same author

Educating Nurses for Genomics-Informed Cancer Care: Strengthening the Current and Future Workforce.

Seminars in oncology nursing·2026
Same author

Seminal Editorial: Who We Are.

Clinical journal of oncology nursing·2025
Same journal

How Can Oncology Nurses Learn to See Beyond the Numbers?

Clinical journal of oncology nursing·2026
Same journal

Care of Patients Receiving Abemaciclib: Results From Clinical Trials and a Healthcare Provider Survey.

Clinical journal of oncology nursing·2026
Same journal

The Role of Oncology Nurses in National Breast and Cervical Cancer Screening Programs.

Clinical journal of oncology nursing·2026
Same journal

Technology-Assisted Nutrition Education Program for Patients With Cancer Undergoing Gastrectomy: A Quasi-Experimental Study.

Clinical journal of oncology nursing·2026
Same journal

The Hidden Biology of Life Experience: Using SEMOARS + GEM and Precision Health for Psychoneurologic Symptoms in Hematologic Malignancies.

Clinical journal of oncology nursing·2026
Same journal

GLP-1 Medications in Oncology Nursing Practice.

Clinical journal of oncology nursing·2026
See all related articles

Related Experiment Video

Updated: Oct 12, 2025

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
05:06

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise

Published on: July 14, 2023

1.9K

Peripheral Neuropathy: Common Side Effect.

Suzanne M Mahon1, Ellen Carr2

  • 1Saint Louis University.

Clinical Journal of Oncology Nursing
|November 20, 2021
PubMed
Summary
This summary is machine-generated.

Peripheral neuropathy, a common side effect of cancer treatment, involves nerve damage causing numbness or weakness. Current care standards rely on evidence-based practices for managing this condition.

Keywords:
cancerlate effectslong-term side effectsside effectssurvivorship caresymptoms

More Related Videos

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
07:42

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity

Published on: April 26, 2012

18.4K
Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
09:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

9.7K

Related Experiment Videos

Last Updated: Oct 12, 2025

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
05:06

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise

Published on: July 14, 2023

1.9K
Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
07:42

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity

Published on: April 26, 2012

18.4K
Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
09:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

9.7K

Area of Science:

  • Neurology
  • Oncology
  • Pharmacology

Background:

  • Peripheral neuropathy is a disease or dysfunction of peripheral nerves.
  • It results in sensory, motor, or autonomic symptoms like numbness or weakness.
  • This condition can be caused by cancer, cancer treatments, or both.

Purpose of the Study:

  • To define peripheral neuropathy in the context of cancer care.
  • To identify common chemotherapeutic agents associated with peripheral neuropathy.
  • To emphasize the importance of evidence-based practice in managing this condition.

Main Methods:

  • Review of established evidence-based practices for peripheral neuropathy.
  • Identification of chemotherapeutic agents linked to peripheral neuropathy.
  • Analysis of the definition and causes of peripheral neuropathy in cancer patients.

Main Results:

  • Peripheral neuropathy affects motor, sensory, and autonomic nerves.
  • Key causative agents include epothilones, platinum analogs, taxanes, and vinca alkaloids.
  • Immunomodulating drugs and proteasome inhibitors are also implicated.

Conclusions:

  • Standards of care for peripheral neuropathy are evidence-based.
  • Understanding causative agents is crucial for patient management.
  • Peripheral neuropathy is a significant complication of cancer and its treatment.